Vermont Will Be Third Northeastern Licensee For Steep Hill’s National Network
Vermont — Steep Hill, a leader in cannabis analytical testing, and the United States’ first commercial cannabis lab, expands with a new licensee partner into the state of Vermont. In 2004, Vermont legalized cannabis for medicinal use and more recently in 2020, Vermont became the 11th state to approve of adult use sales. Licensee Steep Hill Vermont is the first analytics laboratory to receive pre-approval from the State of Vermont.
Steep Hill Inc., CEO, Sameet Kanade, announced, “We are delighted to partner with Steep Hill Vermont, a dynamic, entrepreneurial group with a comprehensive industrial, scientific, and business management background. Their group has rich experience in the cannabis industry, and we look forward to working with them to bring robust safety compliance testing to Vermont’s medical patients and adult consumers.”
Steep Hill Vermont Lab Director Callie Chapman added, “Working with the State of Vermont, our laboratory plans to expand cannabis testing services, while offering quick turnaround times and educational resources for cultivators, manufacturers, and other industry participants. Our goal is to be a key partner in the success of the Green Mountain State’s adult use market and continue to grow our industry.” Steep Hill Vermont is projected to support cannabis and hemp cultivation and processor customers by fall of 2022.
Leading the Steep Hill Vermont team will be:
Kos Parulekar, founding partner & CEO of Steep Hill Vermont has held management roles at multinational entities such as General Electric and The World Bank, as well as with multiple early-stage ventures at the pre-IPO and post-ICO stage. Kos holds a BS in Entrepreneurship from Syracuse University, a MS in Economics from Johns Hopkins University, and an MBA from INSEAD in France.
Dr. Mark Scialdone, founding partner & Chief Scientist at Steep Hill Vermont, is a recognized expert specializing in natural product chemistry including plant oil extraction, analysis, and chemical modification. He is an inventor of 37 issued US patents and has authored 17 publications over three decades of research. Previously, Dr. Scialdone was a research chemist at DuPont for more than 18 years. He holds BS and MS degrees in Chemistry from Michigan Technological University, a PhD in Chemistry from Wayne State University and was a Postdoctoral Research Associate at Colorado State University. Dr. Scialdone is a member of the ASTM D37 Committee on Cannabis, the NCIA Testing Policy Working Group and is a founding member of the Cannabis Chemistry Subdivision of the American Chemical Society. He also serves on the editorial board for the American Journal of Endocannabinoid Medicine.
Callie Chapman, founding partner & Lab Director of Steep Hill Vermont, is a chemical engineer with over 10 years of experience working in the semiconductor and FDA-regulated personal care industry. Prior to Steep Hill Vermont, Callie was the head of the Cannabis Product Development program with her former employer and consulted with cannabis brands across the US. Callie holds a BS in Chemical Engineering from Clarkson University and Graduate certification from the Winkle College of Pharmacy at University of Cincinnati, along with coursework at the University of Vermont.
“What I believe the cannabis industry continues to need is ‘compliantly rebellious’ scientific attitude. An attitude owned by those of us who are not afraid to push on the limits of societal norms while remaining compliant to the science and regulation that governs product safety. This synergy will raise the bar for the entire industry keeping cannabis safe and effective for all who partake.”
Steep Hill Vermont CSO Dr. Scialdone added, “We chose to partner with Steep Hill because of their breadth of experience from opening multiple cannabis testing labs across the country that are considered the gold standard for quality results, rapid turnaround time, and impeccable customer service. Vermont has long had the status of the Humboldt County of the East having a long tradition in cannabis, so opening a testing lab here makes sense on many levels.”
For information, please contact Steep Hill Vermont at: [email protected] or call: (802) 767-7256.
About Steep Hill
Steep Hill is a leading cannabis science company with significant footprints in lab testing and research and development. Steep Hill’s foundation was built on testing and analyzing medical and recreational cannabis to ensure compliance with current safety standards. In 2008, Steep Hill opened the first commercial cannabis lab in the United States. Steep Hill is currently expanding throughout the United States, and globally. Steep Hill: “Globally Driven. Locally Focused.”
- Advocates, parents ‘beg’ Nebraskans to seek out and sign petition to legalize medical cannabis
Advocates for legalizing medical marijuana switched Wednesday from urging Nebraskans to sign their petition to begging them as a July 7 deadline looms to submit signatures to qualify for the ballot in November. - Iowans launch cannabis reform campaign aimed at showing public support
Robert “Lewy” Lewis of Windsor Heights has been in pain since 1974, when he had spinal surgery at the age of 21. To repair a blockage in his spine, surgeons removed eight inches of his vertebrae and then sewed them back on, using about 300 steel stitches. - Big Apple Cannabis: CWCB Returns to New York City for Eighth Year
“No one seems to have gotten it right.” Mayor Eric Adams told a Friday afternoon crowd, of legal cannabis in America. “This is our chance to get it right.” New York City’s mayor addressed attendees of the 2022 Cannabis World Congress & Business Expo (CWCBExpo) on the second day of the three-day event. Adams stressed the social equity focus of New York’s cannabis program. - Nebraska medical cannabis backers file legal challenge to petition process
Supporters of medical marijuana in Nebraska have launched a legal challenge to the state’s requirement that 5% of registered voters in at least 38 counties sign a petition to get the measure before voters on the ballot. - N.J. lawmakers seek to curb cannabis use
As New Jersey nears the end of its first month of legal recreational marijuana sales, lawmakers have introduced a series of bills aimed at restricting what types of workers can use cannabis off the job. - Missouri House votes to require disclosure of medical cannabis ownership records
The Missouri House voted overwhelmingly Tuesday to require state regulators to disclose ownership information for businesses granted medical marijuana licenses that the state has withheld from public view. - Nebraska medical cannabis group calls for ‘grassroots’ effort after losing donor
Unable to raise $1 million to replace funds from a major donor who died, Nebraskans for Medical Marijuana issued a plea Friday for supporters of the cause to take up petitions and gather signatures. - Lawmaker says GOP resistance may doom Missouri cannabis legalization
A Republican lawmaker pushing legislation to legalize recreational marijuana in Missouri says his bill is in jeopardy because of stall tactics by his GOP colleagues and the insistence of the House floor leader that it include license caps. - SD cannabis legalization campaign to submit signatures for November
Today, South Dakotans for Better Marijuana Laws, the political group that led the 2020 campaign to legalize cannabis in South Dakota, submitted petitions to place an adult-use cannabis legalization initiated measure on the November 2022 ballot. - NH senate votes down legal cannabis bills, ending chances for 2022
The New Hampshire Senate voted down two bills to legalize cannabis Thursday, likely heading off the last opportunities for legalization in the Granite State this year.